Whalegun
Home

Regeneron Pharmaceuticals REGN spent $400K on lobbying in Q1 2025 · Taxation, Health Issues and 3 more issues

Trade details

Type
Lobbying report
Amount
$400,000
Quarter
Q1 2025
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
25/04/21

Up 0.0% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN spent $400K on lobbying in Q1 2025 · Taxation, Health Issues and 3 more issues | Whalegun